Pardis Javadi, MD
About me
Areas of Expertise and Research Interests:
- Head and neck cancer
- Thyroid cancer
- Microvascular reconstructive surgery
- Head and neck cancer disparities
Dr. Pardis Javadi is an Assistant Professor in the Department of Otolaryngology Head and Neck Surgery. Dr. Javadi is a head and neck surgical oncologist who specializes in the treatment of head and neck cancer, skin cancer of the head and neck, thyroid and parathyroid neoplasms, and salivary gland neoplasms. She has advanced training in microvascular reconstructive techniques.
Dr. Javadi attended college at Quincy University, in Quincy, Illinois. She earned her medical degree from the Medical College of Wisconsin in Milwaukee. She completed her otolaryngology-head and neck surgery residency at Albany Medical Center and a fellowship in advanced oncologic head and neck surgery and reconstructive surgery at Emory University.
Dr. Javadi's research is focused on understanding factors that affect head and neck cancer outcomes, with the eventual goal to implement interventions to improve outcomes. Her research interests also include studying the effect of the Affordable Care Act (ACA) on head and neck cancers.
She is a member of the American Head & Neck Society (AHNS) and American Academy of Otolaryngology - Head & Neck Surgery (AAO-HNS). She serves on multiple committees with the AHNS as well the SIU School of Medicine.
Videos
Gender
Languages spoken
Education & training
Research
Publications
Javadi P, Sharma S, Zahnd EW, Jenkins WD. Evolving disparities in the epidemiology of oral cavity and oropharyngeal cancers. J Cancer Causes Control;28(6), 635-645
Chen HP, Javadi P, Williams EF. Quantitative assessment of the longevity of Sculptra Aesthetic as volumizing filler using 3-Dimensional photography. Accepted for publication JAMA of Facial Plastic Surgery
Husain KD, Stromberg PE, Woolsey CA, Turnbull IR, Dunne WM, Javadi P, Buchman TG, Coopersmith CM. Mechanism of decreased intestinal epithelial proliferation and increased apoptosis in murine acute lung injury. Critical Care Med. 2005 Oct; 33(10): 2350-7
Vyas D, Javadi P, Dipasco P, Buchman TG, Hotchkiss RS, Coopersmith CM. Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die based on high IL-6 levels. Regul Integr Comp Physiol. 2005 Oct; 289(4): R 1048-53
Javadi P, Buchman TG, Stromberg PE, Turnbull IR, Vyas D, Karl IE, Hotchkiss RS, Coopersmith CM. Chronic iron dysregulation combined with aging prevents sepsis induced apoptosis. Journal of Surgical Research. 2005 Sep; 128(1): 37-44
Javadi P, TG Buchman, Stromberg PE, Husain KD, Dunne WM, Woolsey CA, Turnbull IR, Hotchkiss RS, Karl IE, Coopersmith CM. High dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis. Critcal Care Med. 2004 May: 32(5)1178-85
Tutnbull IR, Buchman TG, Javadi P, Woolsey CA, Hotchkiss RS, Karl IE, Coopersmith CM. Age disproportion ally increases sepsis induced apoptosis in the spleen and gut epithelium. Shock 2004 Oct; 22(4):364-8
Turnbull IR, Javadi P, Buchman TG, Hotchkiss RS, Karl IE, Coopersmith CM. Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with elevated interleukin 6 levels. Shock. 2004 Feb; 21(2):121-5
Husain KD, Stromberg PE, Javadi P, Buchman TG, Karl IE, Hotchkiss RS, Coopersmith CM. Bcl-2 inhibits gut epithelial apoptosis induced by acute lung injury in mice but has no effect on survival. Shock 2003 Nov; 20(5):437-43
Awards
Ben Shuster Memorial Award - Outstanding research paper in Facial Plastic Surgery, 2014
New England Otolaryngological Society - First Place Resident Presentation, 2010
Outstanding Surgical Intern Award, 2009
Albany Medical Center Dean’s List, 1999 - 2001
Quincy University - Outstanding German student award, 2000